New study finds triple-negative breast cancer tumors with an …
WEBApr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.
Estrogen a more powerful breast cancer culprit than we realized
WEBMay 17, 2023 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
WEBJun 7, 2022 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...
Breast cancer vaccine study begins with first patient - Medical …
WEBJun 21, 2024 · Breast cancer vaccine study begins with first patient. by Anya Sostek, Pittsburgh Post-Gazette. An innovative study of a breast cancer vaccine is officially underway, as University of Pittsburgh ...
In Reversal, Expert Panel Recommends Breast Cancer Screening at …
WEBApr 30, 2024 · Citing rising breast cancer rates in young women, an expert panel on Tuesday recommended starting regular mammography screening at age 40, reversing longstanding and controversial guidance that...
Recommendations to begin breast cancer screening at age 40
WEBJun 5, 2024 · All women should begin breast cancer screening at the age of 40, says the U.S. Preventive Services Task Force. In a new recommendation, the task force advises cisgender women and all other people assigned female at birth aged 40 to 74 years get screened every other year.
Breast Cancer News -- ScienceDaily
WEBJun 4, 2024 · Breast cancer research including information on breast cancer symptoms, prevention strategies, screening techniques, and new breast cancer treatments.
Experimental immunotherapy targets metastatic breast cancer
WEBFeb 1, 2022 · Many people with metastatic breast cancer can mount an immune reaction against their tumors, the study found, a prerequisite for this type of immunotherapy, which relies on what are called tumor-infiltrating lymphocytes (TILs).
Antibody-Drug Conjugate Highly Effective in Preventing …
WEBJun 27, 2024 · In a clinical trial involving 512 patients with the earliest stage of breast cancer that tested positive for the HER2 protein, 97% of those treated with trastuzumab emtansine (T-DM1) after surgery were alive and free of invasive cancer five years after treatment. ... News Category. Breast Cancer. Research. Related Doctors and Researchers. Sara ...
Enhertu Effective in HER2-Positive Metastatic Breast Cancer
WEBOct 19, 2021 · In people with metastatic HER2-positive breast cancer, the targeted drug trastuzumab deruxtecan (Enhertu) markedly lengthened progression-free survival compared with trastuzumab emtansine (Kadcycla), new study results show.
Skip to content